AGP Picks
View all

European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on October 30, 2026

Capital Clean Energy Carriers Corp. Announces Third Quarter 2026 Financial Results
Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B
VoidMob Highlights AI Agent Integration Capabilities Through Its Open-Source MCP Server
Double Cross Router and Dalgona Switcher: Analog Tools for Complex Rigs
Analysis of Brineura Market Trends and Forecasts Highlights Significant Long-Term Growth Potential
New Landlord Insurance Website, Landlord Insurance UK, Launches for UK Property Owners
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Transaction in Own Shares
Stallion Uranium Announces Strategic Technical Partnership with Axiom Exploration Group and Corporate Update
EU Retail Leverage Limits Set Minimum Margin at 5% for Gold CFDs and 10% for Oil
Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA
Goliath Resources Closes $9,800,000 Non-Brokered
Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation
Tangram gibt bekannt, dass der erste Teilnehmer im Rahmen der Phase-I-Studie mit TGM-148, einem neuartigen RNAi-Prüfpräparat zur Behandlung von Blutungsstörungen, die erste Dosis erhalten hat
Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
Wolters Kluwer to divest German consumer tax business
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026
Nicox Reports First Half 2026 Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European News Update

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.